Skip to main content
FinSpry Logo
FinSpry
WGS logo
WGS
(NASDAQ)
GeneDx Holdings Corp.
$66.20-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

GeneDx Holdings (WGS) Stock Price & Financial Analysis

GeneDx Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$62.90 - $66.99
52-Week High$170.87
52-Week Low$55.17
Open$63.53
Volume338.57K
Average Volume (3M)338.57K
Market Cap1.78B
Shares Outstanding26.89M
Price to Sales (P/S)4.12
Price to Book (P/B)5.72
EV/EBITDA177.32
Revenue (TTM)427.54M
Net Income (TTM)-21.02M
Free Cash Flow (TTM)14.26M
EPS (TTM)$-0.78
Profit Margin-4.92%
Operating Margin-2.94%
Return on Equity (ROE)-6.82%
Debt to Equity0.49
50-Day MA$83.36
200-Day MA$110.90
52-Week Change-22.54%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About GeneDx Holdings

What is the current stock price for WGS?

As of the latest trading session, WGS stock trades at $66.20. The 52-week range is $55.17–$170.87, with a day range of $62.90–$66.99.

What is the P/E ratio for WGS?

The P/E ratio (Price-to-Earnings) for WGS is shown in the Key Statistics section. This valuation metric helps compare GeneDx Holdings Corp. to industry peers.

Does WGS pay dividends?

GeneDx Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for WGS?

Based on 4 analysts, the consensus for WGS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of WGS?

GeneDx Holdings's market capitalization is $1.78B, classifying it as a small-cap company. GeneDx Holdings operates in the Healthcare sector within the Diagnostics & Research industry.